FLORDELIS REYES: Open Payments
NPI 1841327152 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$95 in 4 payments from 3 companies in 2025. Trend: 2023 $367 · 2024 $618 · 2025 $95
Food & beverage: $95
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 2 | $53 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| Intercept Pharmaceuticals, Inc. | 1 | $20 |
Products named: XIFAXAN, OCALIVA.
Industry payments across NY — which companies pay providers there.
